Advertisement

Mobile Banner
Mobile Banner
Mobile Banner
Loading...

InterCure Ltd.

INCR•NASDAQ
Healthcare
Drug Manufacturers - Specialty & Generic
$0.84
$0.00(0.00%)
U.S. Market is Open • 12:58

InterCure Ltd. (INCR) Stock Overview

Explore InterCure Ltd.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap48.1M
P/E Ratio-2.16
EPS (TTM)$-0.50
ROE-0.17%
Fundamental Analysis

AI Price Forecasts

1 Month$0.71
3 Months$1.75
1 Year Target$0.68

INCR Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of InterCure Ltd. (INCR) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 41.84, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $0.68.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -2.16 and a market capitalization of 48.1M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
4.94%
5-Day Change
-5.74%
1-Month Change
-5.19%
3-Month Change
-32.31%
6-Month Change
-46.01%
Year-to-Date (YTD) Change
-14.56%
1-Year Change
-46.34%
3-Year Change
-68.23%
5-Year Change
-53.68%
All-Time (Max) Change
-74.19%

Contact Information

https://www.intercure.co
972 7 7460 5012
85 Medinat ha-Yehudim Street, Herzliya, NaN, 4676670

Company Facts

3,200 Employees
IPO DateJan 28, 2019
CountryIL
Actively Trading

Frequently Asked Questions